Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

Scientists from the University of St¬†Andrews Infection and Global Health Research Division at the School of Medicine will play a key role in UNITE4TB, a global partnership to accelerate the development of new Tuberculosis (TB) drug regimens, as part of …

15th July 2021 | igh